Related Experiment Video
Updated: Jun 12, 2026
08:26
Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
Fatty acid binding proteins in brain development and disease
Rong-Zong Liu1, Raja Mita, Michael Beaulieu
1Department of Oncology, University of Alberta, Edmonton, AB, Canada.
The International Journal of Developmental Biology
|June 22, 2010
Summary
Long chain polyunsaturated fatty acids (PUFAs) are crucial for brain development, with fatty acid-binding proteins (FABPs) mediating their transport and function. Research explores FABPs
Area of Science:
- Neuroscience and Molecular Biology
- Cellular and Developmental Biology
Background:
- Long chain polyunsaturated fatty acids (PUFAs) are vital structural components for brain development.
- Fatty acid-binding proteins (FABPs) regulate PUFA transport and physiological actions.
- Three specific FABPs (FABP3, FABP5, FABP7) are expressed in the brain.
Purpose of the Study:
- To investigate the distinct spatio-temporal expression profiles of brain-expressed FABPs.
- To elucidate the roles of FABPs in various brain development processes.
- To understand the involvement of FABPs in brain pathogenesis and neuropsychiatric disorders.
Main Methods:
- Analysis of gene expression profiles of FABP3, FABP5, and FABP7 during brain development.
- Functional studies examining the impact of FABPs on neuronal and glial cell generation, differentiation, migration, and patterning.
- Investigation of transcription factor involvement in regulating FABP gene expression.
- Exploration of FABPs as downstream effectors in signaling pathways like Reelin-Dab1/Notch.
Main Results:
- FABPs exhibit dynamic spatio-temporal expression patterns correlating with brain development stages.
- FABPs are implicated in critical developmental processes including cell generation, differentiation, and migration.
- Transcription factors and signaling pathways (e.g., Reelin-Dab1/Notch) regulate FABP expression and function.
Conclusions:
- FABPs are essential regulators of brain development, mediating the functions of PUFAs.
- Dysregulation of FABPs may contribute to brain cancers and neuropsychiatric disorders.
- Further research into FABPs is crucial for understanding brain health and disease.
Related Concept Videos
00:49The Blood-brain Barrier
Overview
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Membrane Fluidity
Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is a relatively...
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is a relatively...